Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Derek Oh and Faraz Nomani Launch Utiva, a Leader in Urinary Tract Health Founded in Canada


News provided by

Mediaplanet

May 17, 2022, 13:00 ET

Share this article

Share toX

Share this article

Share toX


With their potent cranberry PACs capsules, Utiva significantly impacts the at-home prevention of UTIs

NEW YORK, May 17, 2022 /PRNewswire-PRWeb/ --  Utiva has significantly impacted the at-home prevention of Urinary Tract Infections (UTIs) with their Cranberry PACs capsules. A UTI occurs when bacteria adheres to the lining of the bladder. PACs, the bioactive component from cranberries, are known to interfere with the bacteria's ability to latch onto the bladder and urinary tract wall, thus reducing the likelihood of infection. Each Utiva Cranberry PACs capsule contains exactly 36 mg of A-type proanthocyanidins (PACs), the proper concentration clinically proven to help prevent UTIs. It takes a large quantity of cranberry juice and cranberries to provide the necessary concentration of PACs to prevent bacterial adhesion. Therefore, many cranberry supplements are not as effective. Utiva's active ingredient is extracted through a special manufacturing process that concentrates these PACs from the cranberries. The concentration of PACs provided by Utiva is equivalent to nine regular cranberry pills. Cranberry supplements with a high presence of PACs are the only non-antibiotic UTI prophylactic option recommended in both the American and Canadian Urological Guidelines.

"Utiva Cranberry PACs is a non-antibiotic product that I recommend to my patients for UTI prevention," said Dr. Colleen McDermott, MD FRCSC, Urogynecologist. "One Utiva Cranberry PACs pill a day meets the recommended 36 mgs of concentrated soluble PACs required to help prevent UTI recurrences and flush out a wide range of bacteria."

“One Utiva Cranberry PACs pill a day meets the recommended 36 mgs of concentrated soluble PACs required to help prevent UTI recurrences and flush out a wide range of bacteria.”

Post this

Utiva was founded by Canadian entrepreneurs Derek Oh and Faraz Nomani in 2018. The pair met while working at a large healthcare company. They found they shared an entrepreneurial spirit and began brainstorming and researching opportunities where they could further enable self-care and reduce dependence on medications. It was personal experiences that ultimately led them to the development of their first product.

Nomani's grandmother passed away at 51, after neglecting the symptoms of a UTI. She assumed it was something you live with after menopause, and without the proper education and tools, she suffered in silence. She lost a kidney and had severe complications that ultimately lead to her death.

Prior to a trip to Asia, Oh's wife was diagnosed with a UTI. She was given antibiotics and continued her travel plans, only to discover that she was resistant to the antibiotic. Oh woke up to a phone call from the hospital. His wife was overseas with a kidney infection due to the unsuccessfully treated UTI. While she made a full recovery, Oh felt helpless on the other side of the world.

In response to their individual experiences, and after consulting with many urologists and medical experts about gaps in the market, Oh and Nomani founded Utiva. The all-natural, clinically proven Utiva line includes their flagship Cranberry PACs capsules, UTI Diagnostic Test Strips, D-Mannose Capsules, Probiotics and Cleansing Wipes. All products are vegan, halal, gluten-free and non-GMO. All supplements are locally sourced and manufactured to ensure a high-level of quality and consistency.

Unlike most natural health products, the Utiva brand launched with the support of specialists from many of the top academic centers across Canada including Sunnybrook Hospital, London Health Sciences, The Hospital for Sick Children and Hamilton General.

"Our Cranberry PACs are sourced from a supplier in Quebec," says Oh. "Our manufacturing takes place in Toronto. It was a meticulous process to find the right raw materials and GMP (Good Manufacturing Practices) certified facilities to work with and ensure the highest quality products. It was also a priority to support Canadian businesses."

Over the last four years, Utiva has experienced 3 times growth year over year in sales and they expect to double sales in 2022. Utiva is now available in over 2,000 stores across Canada, including Rexall, London Drugs, Jean Coutu, Whole Foods and Healthy Planet, and online at Amazon.ca, Well.ca and Utivahealth.ca.

"We've come a long way from a boot strapped operation," says Nomani. "We have grown from one employee in 2019 to a team of 15 people. We are excited to continue to launch more innovation and raise the awareness and education on how to proactively self-manage urinary tract issues"

Oh and Nomani founded Szio+ Inc., Utiva's parent company, in 2017. Szio+ Inc creates brands that help address chronic conditions with natural products. In addition to Utiva, the company launched Ferosom Forte, a simple and effective liposomal iron supplement with a proprietary LCE coating providing maximum absorption of iron without side effects such as constipation.

ABOUT UTIVA
Utiva is a Canadian brand under Szio+ Inc founded in 2018 by Derek Oh and Faraz Nomani. Utiva is the only healthcare company that offers a complete line of Urinary Tract Infection (UTI) solutions and diagnostics. Utiva's all-natural products use locally sourced ingredients carefully selected for their exceptional quality. Utiva's product line includes Cranberry PACs, D-Mannose, Probiotic, UTI Diagnostic Test Strips, Cleansing Wipes, and a UTI Tracker App.

ABOUT SZIO+ INC
Szio+ Inc. was founded in 2017 by Canadian healthcare industry professionals Derek Oh and Faraz Nomani. Szio+ Inc. strives to provide high-quality, natural supplements that reduce the need for prescription medications. Each individual Szio+ Inc. brand is created to give families the opportunity to take an active role in prevention and wellness. All products are clinically proven, recommended by doctors, and available in Canada and the United States.

For more information, please contact OverCat:
Audrey Hyams Romoff / 647.223.9970, [email protected]
Chelsea Brooks / 289.221.6006, [email protected]

Media Contact

Donna Nuriel, Mediaplanet, 3053007088, [email protected]

SOURCE Mediaplanet

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.